de Jong, Joep J. http://orcid.org/0000-0003-2378-367X
Stoop, Hans
Boormans, Joost L.
van Leenders, Geert J.L.H.
Article History
Received: 19 October 2020
Revised: 22 March 2021
Accepted: 30 March 2021
First Online: 28 April 2021
Declarations
:
: Each author has made a substantial contribution to the article, and has read and approved the final version of the manuscript. JLB is consultant for Bristol-Myers Squibb (BMS), MSD and Roche. GvL has been consultant for Roche and AstraZeneca. The other authors have no conflict of interest to disclose.